Related Experiment Video
Updated: Aug 20, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
[Treatment in the primary prevention of stroke--still not fully used option]
1Klinika kardiologie IKEM, Praha. widimsky@post.cz
Insights
Effective hypertension management, particularly in elderly individuals, significantly reduces stroke risk. Despite proven benefits, only 18% of patients in the Czech Republic receive adequate treatment, highlighting a critical gap in stroke prevention strategies.
Area of Science:
- Cardiology and Neurology
- Public Health
- Pharmacology
Context:
- Hypertension significantly increases stroke risk, especially in elderly populations.
- Stroke incidence has decreased but remains suboptimal, with only 18% of patients effectively treated in the Czech Republic.
- Systolic blood pressure is a more critical prognostic factor than diastolic pressure in hypertensive patients over 50.
Purpose:
- To evaluate the effectiveness of hypertension treatment in reducing stroke incidence.
- To identify factors contributing to uncontrolled hypertension and stroke occurrence.
- To emphasize the importance of combination therapy and 24-hour blood pressure control in elderly patients.
Summary:
- Pharmacological treatment of hypertension, particularly isolated systolic hypertension in the elderly, can decrease stroke incidence by over 40%.
- Inadequate hypertension control, often due to minimal combination therapy, contributes significantly to stroke events, even in treated patients.
- Calcium channel blockers or diuretics are recommended for isolated systolic hypertension in the elderly, with a focus on achieving 24-hour blood pressure control.
Impact:
- Improving hypertension management could substantially decrease stroke incidence, with significant potential for public health improvement.
- Addressing the under-treatment of hypertension presents a major opportunity to reduce the burden of stroke in the population.
- Evidence supports blood pressure reduction for both primary and secondary stroke prevention, even in normotensive individuals.
Abstract:
Several studies have shown that pharmacological treatment of systolic-diastolic hypertension or isolated systolic hypertension in elderly persons would result in several years in a significant decrease (more than 40%) of stroke. Occurrence of strokes decreased in the Czech Republic in years 1985 till 2002 by more than 40%, which represents about two thirds of the decrease observed in the USA. Nevertheless, we cannot be satisfied with the treatment of hypertension in the Czech Republic because only 18% of patients are effectively treated for the hypertension, with BP < 140/90 mm Hg. Not well controlled hypertension results namely from the minimal use of the combination treatment. From the point of prognosis for the hypertensive patients older than 50 years, the level of systolic pressure is more important than the diastolic pressure. The risk of development of the stroke rises from the level of systolic blood pressure 115 mmHg almost linearly. Calcium channel blockers or diuretics represent the most appropriate therapy of the isolated systolic hypertension of elderly patients. The risk of stroke is higher also in persons with elevated blood pressure in the morning. That is why in elderly patients the use of drugs effectively controlling blood pressure during 24 hours is necessary. Recent studies (HOPE study, PROGRESS study) have demonstrated that the reduction of blood pressure decreases the occurrence of stroke not only in hypertensive patients, but also in the normotensive persons during the primary and secondary prevention. Review data show that 27% of ischemic strokes and 57% of hemorhagic strokes, which happened in the "treated" hypertensive patients, are due to not well controlled hypertension. Missing treatment of hypertension is responsible for 22.8% of strokes in men and 25.4% in women. The given data show a big reserve for the possibility to decrease further the stroke incidence in the population.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Ischemic Stroke l: Introduction
Atherosclerosis III: Management
Preventive Healthcare Services
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...